Fluorine Scanning by Nonselective Fluorination: Enhancing Raf/MEK Inhibition while Keeping Physicochemical...

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Drug Discovery

Background:

• Fluorine incorporation is a key strategy in medicinal chemistry to modulate drug properties.
• Developing efficient methods for selective fluorination remains a challenge.
• Understanding the impact of fluorine substitution on biological activity is crucial.

Purpose of the Study:

• To report a facile synthetic methodology for generating monofluorinated compounds via a fluorine scan.
• To evaluate the impact of monofluorination on physicochemical properties and biological activity.
• To identify novel drug candidates with improved therapeutic profiles.

Main Methods:

• Direct and nonselective fluorination of a lead compound (1a) and key intermediate (2a).
• Synthesis of six monofluorinated derivatives.
• Assessment of physicochemical properties and Raf/MEK inhibitory activity.
• In vivo evaluation of lead candidate (14d) in a xenograft tumor model.

Main Results:

• A facile methodology successfully produced six monofluorinated derivatives.
• Monofluorinated compounds retained physicochemical properties similar to the parent compound.
• One derivative exhibited enhanced Raf/MEK inhibitory activity.
• Compound 14d demonstrated potent tumor growth inhibition, favorable pharmacokinetics, and no critical toxicity in animal models.

Conclusions:

• Monofluorination is a viable strategy to fine-tune drug properties without significant alteration.
• The developed synthetic route provides access to valuable fluorinated analogs for drug discovery.
• Compound 14d represents a promising anti-cancer therapeutic candidate with a strong preclinical profile.